When: Retest of $420 zone OR Q3 FY26 working capital confirmation

Then: Add 50% of target position

When: Pullback to $340–$350 pricing in goodwill risk

Then: Highest-conviction add of all three tranches

BUY (reduced size, wider stop, patient entry)

• 50-day SMA rejected for 5 consecutive weeks; VWMA declining from 410 to 383; daily true range $17
• Current price $390 sits directly below major resistance at $395 with no volume confirmation
• Recommended entry: pullback to $385-$375 zone aligning with 10 EMA, Bollinger middle band, and 83-session low
• VWMA declining from 410 to 383 indicates bearish momentum
• Goldman conviction list removal causes reputational drag lasting a full quarter, not just 1-3 weeks of flow impact
• Two independent negative signals (Goldman exit + EU legal loss) landing in same window = compounding effect
• VMware goodwill of $126B represents 70% of total assets with zero visibility into EU document production
• 200 SMA at $365 provides only 6.5% downside buffer; ATR of $17 means 4-5% daily moves are routine
• Proposed stop at $372 too tight; would get clipped by routine intraday volatility before thesis plays out
• Conservative stop recommendation: $368 (just above 200 SMA) to allow room for normal volatility flush
• Forward EPS of $19.49 assumes 225% expansion from trailing $5.99; any headwind compresses earnings significantly
• At $18 EPS, forward PE goes from 20 to 22; at $17 EPS, forward PE goes to 23
• Receivables grew 158% ($6.5B to $16.7B) in 3 quarters vs. 48% revenue growth = $10B+ working capital drag
• Inventory more than doubled, requiring monitoring as leading indicator
• Recommended tranche one: 15-20% of target (vs. 25%), with 1.15% of total capital at risk on full position
• AMD earnings on August 4th is a known catalyst cluster; avoid adding to position during elevated information window
• Patience represents optionality, not cost; waiting 2 weeks preserves ability to deploy at maximum clarity
• Marvell dropped 32% in one month on AI sentiment shift illustrates how quickly sentiment can reverse
• Forward PE of 20x and PEG of 0.44 appear attractive but require extraordinary growth assumptions to hold
• Buy supported but with smaller size, wider stop, and reserves held for confirmed breakout or genuine flush

→ vs aggressive: Technical analysis is survivorship bias dressed up as analysis; five-week rejection pattern is not a breakout precursor, it's a warning sign

→ vs aggressive: Goldman removal is not just a flow event; it's a reputational signal to pension consultants and gatekeepers that drags for a quarter, not 1-3 weeks

→ vs aggressive: Treating Goldman exit and EU legal loss as independent isolated incidents ignores correlated signal compounding; risk discipline treats them as a pattern

→ vs aggressive: EU VMware situation dismissed as procedural with years to outcome; goodwill of $126B (70% of assets) requires monitoring, not dismissal

→ vs aggressive: 200 SMA at $365 is hope, not guarantee; Marvell dropped 32% in a month on AI sentiment shift shows how fast support levels evaporate

→ vs aggressive: Forward EPS of $19.49 is an extraordinary assumption; any moderation in capex, pricing pressure, or slower VMware synergies compresses earnings and expands PE

→ vs aggressive: Receivables growing 3x faster than revenue is not benign; $10B+ working capital drag is real cash tied up that creates future quarter risk

→ vs aggressive: Entry at $390 with stop at $372 offers no margin of safety; ATR of $17 means the stop gets clipped by routine volatility before thesis has a chance

→ vs neutral: Waiting for confirmed close above $395 on volume is correct; this is process, not cowardice

→ vs aggressive: Patience is optionality, not a cost; waiting 2 weeks resolves AMD, EU ruling, and Goldman overhang without sacrificing the thesis

BUY (scaled entry with adjusted sizing and timing)

• Reduce tranche one from 25% to 15-20% of target weight
• Keep entry zone at $385-$395
• Widen stop to $367, just below the 200 SMA at $365
• Hold 50-55% of capital in reserve split between confirmed close above $404 on volume and flush to $340-$350 zone
• Do not buy into AMD print; wait one day and initiate tranche one on Wednesday or Thursday based on post-event tape
• Receivables grew from $6.5B to $16.7B in three quarters ($10B working capital increase) represents a yellow flag requiring monitoring
• Consolidation is unresolved but stock holding above 200 SMA by 7.5% with MACD histogram crossing positive shows structural resilience
• EU VMware goodwill of $126B is real but procedural ruling is not substantive to underlying business
• Company generating $27B trailing FCF with net debt down $8B in three quarters
• Architecture of scale-in with defined risk and conditional adds is correct

→ vs aggressive: Confirmation trading with a $372 stop (1x ATR) into AMD report tomorrow is not positive expected value; stop gets clipped on open if AMD disappoints and AVGO gaps down 5%, or trader is chasing if it gaps up 4-5%

→ vs aggressive: Receivables growing from $6.5B to $16.7B is a cash conversion risk even with investment-grade credit; $10B tied up working capital is not available for buybacks, dividends, or deleveraging

→ vs conservative: 5-week rejection argument applies survivorship bias; stock holding 7.5% above 200 SMA with MACD crossing positive shows structural resilience, not just consolidation

→ vs conservative: Stop at $368 is only $3 above the 200 SMA at $365; if AVGO breaks the 200 SMA on volume, stop gets clipped anyway; has not addressed underlying structural vulnerability

→ vs conservative: EU VMware situation is being overstated; document production ruling is procedural not substantive, goodwill impairment is non-cash, and FCF trajectory contradicts impairment narrative